Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd
Japan
Pharma
Shionogi's Japan-approved antiviral nets US COVID nod
Shionogi has secured an FDA green light for its Japan-approved COVID-19 antiviral Xocova in the prevention setting.
Fraiser Kansteiner
Jun 1, 2026 11:11am
More biotech hawkishness, Pfizer’s $10B deal—Fierce Pharma Asia
May 29, 2026 8:30am
Global pharma leaders convene in Japan
May 28, 2026 11:37am
Tavneos patient starts resume in Japan amid safety scrutiny
May 21, 2026 11:38am
AstraZeneca CEO outlines conservative forecast model for MFN
Apr 29, 2026 3:08pm
Daiichi Sankyo plots $1.5B consumer health unit sale to Suntory
Apr 15, 2026 3:22pm
